Serum soluble suppression of tumorigenicity-2 level associates with severity of pulmonary hypertension associated with uncorrected atrial septal defect

Serum soluble suppression of tumorigenicity-2 level associates with severity of pulmonary hypertension associated with uncorrected atrial septal defect

Uncorrected atrial septal defect undergoes right ventricle chronic volume overload which may lead to pulmonary hypertension and Eisenmenger Syndrome. The soluble suppression of tumorigenicity-2 is a left ventricle strain biomarker; however, its role in right ventricle strain is unclear. This study a...

Full description

Bibliographic Details
Main Authors: Reza S. Pratama, Anggoro B. Hartopo, Dyah W. Anggrahini, Vera C. Dewanto, Lucia K. Dinarti
Format: Article
Language:English
Published: SAGE Publishing 2020-05-01
Series:Pulmonary Circulation
Online Access:https://doi.org/10.1177/2045894020915832

Similar Items

Similar Items